Axis Exports To China Police Criticized By Amnesty International

By IPVM Team, Published Sep 21, 2020, 12:56pm EDT

Axis Communications and other EU surveillance providers are under fire from Amnesty International over sales to police in China (PRC) that Amnesty says contributes to "indiscriminate mass surveillance" in the country.

IPVM Image

While China's vast police video surveillance market is dominated by homegrown giants Hikvision and Dahua, Axis has offices in Beijing and Shanghai and its resellers have supplied multiple PRC police projects, Amnesty International revealed in a new report.

Amnesty's report showcases the PR and compliance risks for Western surveillance manufacturers of doing business in the PRC due to its poor human rights record, even in cases like Axis' whose China presence is tiny.

Amnesty ****** **********

******* ************* ********************* ****** "*** ** Control"******** ** ***** ******** companies' **** ** ************ tech ** *****, ******* for ****** ******** ** this ********:

IPVM Image

**** ** ************* ** Sweden, ***** ** *****'* Canon. *** ***** *** companies ****** *** **** French ********** ***************** ***** ********** ********* firm******.

Prior ** "*******" ** *******

******* ***** **** *** report ** ********* "***** of * ******* ******* in ******** ** ** September ***** *** ******** Parliament [...] **** ****** whether ** ********** *** surveillance ****** *****." **** was ****** ** **** a ****** ** **** specific ******* *** **** reached *** ** ******* and *** ** ** confirm *** *******.

Axis ***** ****** ******* ********

** *****, ******* ********** multiple "************" ** *******, noting **** **** *** two *****-***** ***** ******* in *****: *** ** Beijing *** *** ***** in ********.

  • ******** ****** ************* ******* **** ** Axis ********, **** **** confirming ** ******* **** it *** **** **** of "**** ************ ********" in ******** **** ****IPVM Image** ****.
  • **** **** ******** ** was **** ** ******* "city ************ *******" ** Wuhan ******** "******* ************* did *** ******* *********** this".
  • ********* ****** ****** ********* Axis ********* ******* * "local ******* ******" ****** multiple ******* ******* **** and ****.
  • ***** ****** **** *********** on ****' ********* ********* **** *** traffic ************ *** * local ***********.
  • ***** ****** **** **** touted ** ****** ****** **** *** a ***** ***********.

Contrast ** ***** *** ********* ********

* ***** ********** **** Axis ***** ** **** none ** ***** ******** were ****** ***** **** Axis ** *** *** while ***** *** ********* have ******** ** ******* of **** ****** ************** **** $* ******* in ********.

Tiny ***** ****** *****

**** ********* **** **** currently *** * **** than *% ***** ** the ***'* **** ***** surveillance ******, ***** ******** hugely **** ********** ******** via ************ ****** *** ***** Eyes.

**** ****** ***** ****** of *** *** *** actually ********* **** *** past ****** ** *** PRC ********** ******** **** largely ****** **** *********** ******* *** *** regularly ********** * ******** risk.

Summary ** ******, ****** **********

******* ****** ** ******** a ****** ******* **** Morpho, * *********** **** to *****'* ******, **** facial *********** ** ******** police ** ****. ****** had **** **** ********* China **********, ******* ****** expression ********* ******** ** recent ***** ** *****'* central ****** ********* (*** Ministry ** ****** ********) and ** **********-*** ************ in ********.

Why ******* ** *********

******* ********* **** *** police ***** ************ ******** "amount ** **** ************" because ** *** "************** application" ** ***** ************ in ***** *** **** of *** "******** ***** rights **********":

IPVM Image

******* ******* ** ***** surveillance-fueled ************** ******* *** Uyghur ******** ****** ** China, *** ** ****** deployment ** ****** *********-*********** analytics:

IPVM Image

****'******* **** **** ******* police *********** *** ********* Uyghur ************** ***** ** *** Amnesty ******:

IPVM Image

Axis' ******** ** *******

****** *** ******, **** responded **** ** *** not ***** ** *** mass ************ ************ ** the **** ** *** publicly ****** ***** **** 2012 *** ****:

**’* ******* **** **** of *** ******** *** refer ** **** ********* as * “******** *******” on *** *******. **** Axis **** **** ** those ********, ** *** no *********** **** *** customers ********** **** *** products ***** ** **** for ******** **** ***** risk ********* ***** ******

** ** *** **** recent **** ********* ********* by *** ******, **** explained ** ******* **** this *** *** ** resellers, ***** **** ******* "to ****** *** **** of [****] ******** ***** used ** * ***-******** way". ************ ** ********** *********** ******** ** *** report *** *** ** its *******, ****** ** would ******* "******* ********** use *****".

Amnesty ***** **** "**********"

*******, ******* ********** ****' response, ****** *** **** "heavily ****** ** *** information **** **** ******* from ***** ********* [*********]" and **** **** ** "inadequate":

IPVM Image

******* ********* **** **** "did *** ******* ********** evidence" **** ** *** fulfilled *** ***** ****** due *********:

IPVM Image

** ********, ******* **** it "********" ****** *** instituting * ******* *** on *** ****** ***** since ****. ** ** sure, **** ** **** were ** ******** **** a ******, *** *** of ***** ********* ***** may ***** ********** *** effectiveness.

Axis' ********** ******

**** *** **** ****** pledges ******, ******* ** 2018 **** ****' ********* Ray **************** ******************** ******, ***** ******* ************ and **** ***** ******** by "********** ************":

IPVM Image

Axis ******** ** ****

**** ********* ** * number ** ********* **** asked:

Why **** **** ******** ******* ** *******/******** *** ****** ***** ** *** *** ***********, ***** *** *** **********'* ********* ******* ** ***** ******-******* ***** ************ ************?

***** **** ** * global ****** *** ***** is *** *****’* ****** largest ****** *** ******* video, **’* ******* *** us ** **** ******** in **** ******. *** of ****** ** *** aware ** *** ***** rights ******** ** ***** when ** ***** ** video ************. ** ******** to *** ********* ********* processes (********* **** ** detail *****), *** ******** with ******** *** *** users *** **** ** identify ******* ********. ** decline ****** ***** ** projects **** ** **** clear ******* ** ******* that *** ******** ***** be **** ** ** unethical ***.

Also, ****** *** '***** ************', **** ***** *** ********** ****** **** **** *** ******, **** **** ******** ***** **** ** *** ****** ******* ****?

******* ******* *** **** by *** ************ *** over *** ***** *** many **** ********. ****, Axis ******* ******** ** PRC ******, ***** ********** a **** ***** **** of *** *****, **** not ************* **** *** violation ** ***** ******. What ******* ** *** and *** **** ******** purpose **** ****** ** use *** *********. ** we **** *** ********** that *** **** ******** will ** ** ********** with *** **********, ** can ******* **** *** project. *********, ** *** decline. ** ******* **** approach ** ******* **** the ********** ** *** Copenhagen ******.

Axis ****: "********* *** ************** ******** ** ********* *** ***** ************ ** ********* ** ***** ** ******** *** ************* *********." *** **** ********* ** ****? ************, **** **** **** **** ** '********'? **** **** **** *** **** ** **** ********, ************ **** **** ***** ******** **, ******** **** *** **** ************?

**** ** ***** ** our ************, ***** *** Axis ****** *********, ** automatically ****** ******* ****, as **** ** ******* and ******** ******* ** each *****. ** **** have ** ********* ********* for ***** *********** ** our *******, **** ** information ***** ******** *** system *********** ******** ** a ********-***********, *** *********** about ***-***** ** ******** (i.e. ** **** *********** about *** *** ****). Also, *** ************ *** contractual ***** ** ****** with ********** ****** ******* and ********* ************. *** all ******** ***** ****** control, ***** ******** ************ apply ** *** ***/*** user, **** *********** ** screened ** ****.

**** **** ********** ** what ** ***** ** decline ** **** **** in * *******:

** **** *****, ** don’t **** *********** ***** the *** ********. **** we *** **** ** decline ****** **** ** projects, ** ***** **** we ****** *** ** take ** ****** **** in * *******, *** we ** ****** ** inform *** ******** ***** our ******** ** **** it’s *** ****. *** it’s ********* *** ** to **** * ******** from ******* *** ********.

**********

****** ***** *** *********, who **** ******* ******* from **** ********, **** makes **** ******. ******* this, ***** **** *** actively ****** ** ******* such ********, **** ** clearly ******* ** **** criticism.

Vote / ****

Comments (10)

******:******* ***** **** ***** would ** * "******* meeting ** ********" ***** where ** ********** "**** decide ******* ** ********** lax ************ ****** *****." An ** ************ **** IPVM "***** ******** *** *** open ** *** ******" and "***** ** ** livestream."

*******, *** ** *********** tweeted ***** *** ******* today ****** **** ************ on ***** ***** *** getting ****** ** ******** up. ****** *** ***** Lange***** ****"*** *********** **** ** near"***** *** **'* ****** Trade ************* ******** *****"*********** ********* *** ******* within *****".**** **** ****** **** the ***** *** ***** upon.

*** **** *** ***** JUST *** ******!!!

** *** **** **** only ******** *** ********* in ******* ***** ****** abuses *** ******* ************* have ** ********* ** their ******, ***** ** all *** ** ***** industry **** ******** ****. This ****** ** ********* fake **** ******* ******** otherwise ***** **** ** far *** **** *** faced ************* **** ****** on **** *****. ****** retract **** ******* ** soon ** ******** ** we *** ******** ** brow **** ****** *** uses ******** ***** ******* smug ** *** *** reproachless ********.

***, **** ** *** predictably ******** **** ******* with ***** ********* ***** and ** ********** ** debate *** *****. ***'* that **** *****, ******?

******, *** ******* **** me ** **** *** Amnesty ****** ***** **** condemn, *** ********* ******* manufactures *** ***** ******* contribution ** *** ***** rights ********* ** *****? I'm **** ******* *** the ********* ******** ** Amnesty ** *** ** authorities ** *** ***** those ******* ** **** in *** ** *********. Any ********** ** **** organization ********** ****** ***** by ********* **** *** applying **** **** **** try ** ******* ** the ****. *** *'* maybe ***** *** ***** reports ***** *** **** been ****** ****** *** I ****** ****.

** *******, ****** *** your *******! *** * don't ***** ******* ** purposefully ******** *********/***** ** is ******* ** **** their **********. *******'* ****** specifically ******* ************ ************* in ****** ******* *** EU *********** ******* **** ****** controls*** **-**** ************ ****. There ** ** ********** EU ******** ** *****/*** certain********* ************ ****; *******, I ** ***** *** make * **** ***** that ******* ****'* ********* the ** (*** ***** places) ****** **** ** given *** ***** ****** situation ** *****. **** the ** - ***** has********************** ***************/***** - ***** ******* sale ** ***** ******** (to ***-******* ********) ************.

* ******'* **** *** Amnesty ******* ************ ******** of *********/*****. *******, ******* has **** **** ******** of ******* ********** ************/********** in ********:

**'* **** **** ***** Rights *****, * ******** but ******* ****-******* ***** rights ***, *** ******* the ******* ************ ***************************.*** *** **** **** Amnesty ***** *****'* ***** the ***** **** ****** as *** *****'* ******** anything *********; **** ******** to ****** ** **** organizations, **** *** **** similar *** **** ***'* want ** ****** **** other.

****** ******* *** **** comments *** ******** ****. Sure, *****'* ** ********** purpose ** ************ * brand **** **** (*** other *** ** ******) while *** ********** ** all *** ******* ******, one ** **** ***** by *** "******" ******* government ******* **********.

* *** ********** *** strategy ** ******* ** push *** ** ********** to *** **** ************ on ******* ** *****, but, ** *** ******* out, *****'* ** ******** strategy ** ******** *** exports ** ***** ******* government ***** ********* **** EU.

** ********** ************* ***** brands, ******* ** *********** the *********** ** ***** names **** *** ********* of ***** ****** ** China. *************, *********** *** Chinese ********* *** *** Axis' **** ***********. * don't **** **** **** could ******* **** *** EU ***********, *** **** they **** **** ** far ** ** **** most ** *** ******** media ******* *** ******* of **** ******** *********** of ***** ****** ****** and **** *********.

** ******* ****** ** be **** ****, **** should **** ******* *** Chinese ****** *** ***** level ************* ** *** activities **** ***** **** is ********. **** ***** show *** ****** ********* of *** *********. ** you *** *******, *** has **** **** ** name ***** ****** **** analyzing *** *******. ** not ****** **** **** if **** *** ** present ** ** * EU *******, *** ******* video ************* ******** *** also **** ** *** EU ********* ******* ************.

** ** **** ******* for **** *****, **'* very *********** ** **** to **** *****, ***** we **** *** **** efforts ****** ***** ** differentiate *** ********* **** values *** ******.

*******, * ********** ********** your ***** *** * think ** ***** **** some ********** ** ******* it ** ******* ** allow *********/***** ***** ** the ** ** *** is *********. *******, * do ***** **'* ********** that **** - * Europe ************* ************ **** tiny ***** ***** - still ****** **** "******* products ** *** ****** [...]**** *** ************* **** any ********* ** ***** rights." **** ** * notable ***** *** **** to **** ******* ******* (as *** ******* ****** notes) ****** **** ******* otherwise, **** ******'* ****** banning ***** ** *** law *********** ***** ****. If **** ***** ** truly *********** ****** **** the ******* ************* *** are **********, *** *** take * ***** ******* to ******'*?

*******, ********* ** ********* to ******* ******, ***'** understand **** * **** stick ** ** *******'* official ***** **** **** been ****** ******* ** the ******* *****. *** are ***** ***** *** the ********** ****** ** focused **** ** ** PRC ****** ****** ** banned ** * ******** for *** ** ********* or ***** *** ******* Government ********* ********. ** Axis *** ***** *** same ****** ** ****** in **** *****, ** something * ** *** in *** ******** ** evaluate, *** * ***** there ***** ** ******** differences. **** *** ****** a ****** ********** **** ethic ********* ****** ***** and * **** ** doubt **** ** **** be ********* ** **** in *** ********* ** the ******.

* **** ** ******* though, **** * ** not ******* *** ******* manufacturers. * ** ******* with **** ** *** market. * *** ***** with *** ******* ** perverse ********* *** ***** rights **********, *** ******* those *** ******** *********** in ****. * **** have *** *********** ********* in *** ***** *** the ******** **** *** US *********** **** ****** some ******.

** ** **** ** make ******* ******** *********, China ***'* ** ******* to ******** **** ********** countries **** **** ******* human ****** *** **** free *****. **** ******* a *** ** ***** from ***** ***** ****** on *****. *** ***** to **** ***** ***** price ****** ********* *** to ***** **** * company **** ****.

** ***** ******* *** world's ******* *******, ********** countries *** ************* ******** like **** **** ****** that ***** *** ******* their **** ** ******** the *****. **** *** China **** ****.................**** *** not ****** ***** **********

**** **** *** *** material *** ********** ********** Axis ********** ******** ********. It ** *** ***** finding *** ****** **** supply *****, ** ****** the ********* ************* ********** and ***** ****** ******. FREE ***** ** * slogan *** ***** * true ******** *** ************* caplistist *********. **** ** in *** *** *** only ******* ********** *** Chinese *******. ** *** are ** ************* *** know **** ** ****!

Read this IPVM report for free.

This article is part of IPVM's 6,814 reports, 914 tests and is only available to members. To get a one-time preview of our work, enter your work email to access the full article.

Already a member? Login here | Join now
Loading Related Reports